Navalign, LLC

Position in ZTS — Zoetis Inc.

CIK 1820593 ENCINO, CA

Position in ZTS

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$438,992

-$235,277 QoQ

Shares Held

6,109

+7.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#819

of 1,408 holders

Holding Since

Jun 2021

21 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Navalign, LLC holds $745,397 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (58.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ZTS	Zoetis Inc. This page	6,109	$438,992
2	NBIX	Neurocrine Biosciences Inc	1,818	$306,405

21 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$438,992	6,109	+7.1%	Shares	Sole	2026-07-28
2026-03-31	$674,269	5,704	+3.8%	Shares	Sole	2026-04-29
2025-12-31	$691,506	5,496	+0.1%	Shares	Sole	2026-02-05
2025-09-30	$803,150	5,489	-5.9%	Shares	Sole	2025-11-13
2025-06-30	$909,344	5,831	-0.3%	Shares	Sole	2025-08-05
2025-03-31	$963,202	5,850	+3.8%	Shares	Sole	2025-04-30
2024-12-31	$918,599	5,638	+3.9%	Shares	Sole	2025-02-18
2024-09-30	$1,060,131	5,426	-0.4%	Shares	Sole	2024-11-01
2024-06-30	$944,638	5,449	+7.9%	Shares	Sole	2024-07-30
2024-03-31	$854,341	5,049	+3.3%	Shares	Sole	2024-04-12
2023-12-31	$964,744	4,888	+4.4%	Shares	Sole	2024-01-18
2023-09-30	$814,226	4,680	+0.2%	Shares	Sole	2023-10-11
2023-06-30	$804,565	4,672	+4.9%	Shares	Sole	2023-07-14
2023-03-31	$740,990	4,452	+47.3%	Shares	Sole	2023-04-20
2022-12-31	$443,020	3,023	-36.2%	Shares	Sole	2023-02-07
2022-09-30	$702,598	4,738	+3.1%	Shares	Sole	2022-11-03
2022-06-30	$790,178	4,597	-9.7%	Shares	Sole	2022-07-27
2022-03-31	$959,923	5,090	-1.3%	Shares	Sole	2022-04-29
2021-12-31	$1,258,462	5,157	-5.5%	Shares	Sole	2022-02-08
2021-09-30	$1,060,004	5,460	—	Shares	Sole	2021-11-03
2021-06-30	$978,000	0	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.